84
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Plasma Fatty Acids as Surrogate for Prostate Levels

, , , , &
Pages 45-50 | Received 11 Apr 2017, Accepted 25 Aug 2017, Published online: 21 Dec 2017

References

  • Chapkin RS, Kim W, Lupton JR, and McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81, 187–191, 2009. doi:10.1016/j.plefa.2009.05.010.
  • Pandalai P, Pilat M, Yamazaki K, Naik H, and Pienta K: The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res 16, 815–820, 1995.
  • Rose DP and Connolly JM: Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18, 243–254, 1991. doi:10.1002/pros.2990180306.
  • Karmali R, Reichel P, Cohen L, Terano T, Hirai A et al.: The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor. Anticancer Res 7, 1173–1179, 1986.
  • Szymanski KM, Wheeler DC, and Mucci LA: Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr 92, 1223–1233, 2010. doi:10.3945/ajcn.2010.29530.
  • Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL et al.: Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86, 281–286, 1994. doi:10.1093/jnci/86.4.281.
  • Laaksonen DE, Laukkanen JA, Niskanen L, Nyyssonen K, Rissanen TH et al.: Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort study. Int J Cancer 111, 444–450, 2004. doi:10.1002/ijc.11614.
  • Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE et al.: Prediagnostic level of fatty acids in serum phospholipids: O-3 and O-6 fatty acids and the risk of prostate cancer. Int J Cancer 71, 545–551, 1997. doi:10.1002/(SICI)1097-0215(19970516)71:4<545::AID-IJC7>3.0.CO;2-U.
  • Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ et al.: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst, 105, 1132–1141, 2013. doi:10.1093/jnci/djt174.
  • Brasky TM, Till C, White E, Neuhouser ML, Song X et al.: Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 173, 1429–1439, 2011. doi:10.1093/aje/kwr027.
  • Aronson WJ, Kobayashi N, Barnard RJ, Henning S, Huang M et al.: Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res (Phila) 4, 2062–2071, 2011. doi:10.1158/1940-6207.CAPR-11-0298.
  • Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF et al.: Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 17, 3577–3587, 2008. doi:10.1158/1055-9965.EPI-08-0008.
  • Moreel X, Allaire J, Leger C, Caron A, Labonte ME et al.: Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance. Cancer Prev Res (Phila) 7, 766–776, 2014. doi:10.1158/1940-6207.CAPR-13-0349.
  • Reinders I, Song X, Visser M, Eiriksdottir G, Gudnason V et al.: Plasma phospholipid PUFAs are associated with greater muscle and knee extension strength but not with changes in muscle parameters in older adults. J Nutr 145, 105–112, 2015. doi:10.3945/jn.114.200337.
  • Folch J, Lees M, and Sloane-Stanley G: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497–509, 1957.
  • Schlierf G and Wood P: Quantitative determination of plasma free fatty acids and triglycerides by thin-layer chromatography. J Lipid Res 6, 317–319, 1965.
  • Lepage G and Roy CC: Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114–120, 1986.
  • Haest CWM: Distribution and Movement of Membrane Lipids. In Red Cell Membrane Transport in Health and Disease, Bernhardt I and Ellory JC (eds.). Berlin, Germany: Springer Berlin Heidelberg, 2003, pp. 1–25.
  • Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT et al.: Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 92, 1214–1222, 2010. doi:10.3945/ajcn.2010.29182.
  • Phillips GB and Dodge JT: Composition of phospholipids and of phospholipid fatty acids of human plasma. J Lipid Res 8, 676–681, 1967.
  • Hodson L, Skeaff CM, and Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47, 348–380, 2008. doi:10.1016/j.plipres.2008.03.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.